This company has been marked as potentially delisted and may not be actively trading. BiondVax Pharmaceuticals (BVXV) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock BiondVax Pharmaceuticals Short Interest DataBiondVax Pharmaceuticals (BVXV) has a short interest of 4,900 shares. This marks a 36.11% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 127,289 shares to cover all short positions.Current Short Interest4,900 sharesPrevious Short Interest3,600 sharesChange Vs. Previous Month+36.11%Dollar Volume Sold Short$6,419.00Short Interest Ratio0.0 Days to CoverLast Record DateAugust 15, 2023Outstanding Shares1,870,000 sharesPercentage of Shares Shorted0.26%Today's Trading Volume23,000 sharesAverage Trading Volume127,289 sharesToday's Volume Vs. Average18% Short Selling BiondVax Pharmaceuticals? Sign up to receive the latest short interest report for BiondVax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBVXV Short Interest Over TimeBVXV Days to Cover Over TimeBVXV Percentage of Float Shorted Over Time BiondVax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20234,900 shares $6,419.00 +36.1%N/A0 $1.31 7/31/20233,600 shares $4,788.00 -25.0%N/A0 $1.33 7/15/20234,800 shares $6,960.00 -53.4%N/A0 $1.45 6/30/202310,300 shares $14,523.00 -80.9%N/A0.1 $1.41 6/15/202353,800 shares $74,782.00 +232.1%N/A0.3 $1.39 5/31/202316,200 shares $28,674.00 -10.0%N/A0.1 $1.77 5/15/202318,000 shares $32,907.60 +20.8%N/A0.7 $1.83 4/30/202314,900 shares $28,757.00 +17.3%N/A0.4 $1.93 4/15/202312,700 shares $22,733.00 -40.1%N/A0.2 $1.79 3/31/202321,200 shares $45,792.00 -52.0%N/A0.2 $2.16 Get the Latest News and Ratings for BVXV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BiondVax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/15/202344,200 shares $95,030.00 +13.9%N/A0.3 $2.15 2/28/202338,800 shares $91,374.00 +10.2%N/A0.2 $2.36 2/15/202335,200 shares $85,536.00 +5.7%N/A0.2 $2.43 1/31/202333,300 shares $86,913.00 -40.3%1.8%0.2 $2.61 1/15/202355,800 shares $157,356.00 +206.6%3.1%0.4 $2.82 12/30/202218,200 shares $53,872.00 -52.5%1.0%0.2 $2.96 12/15/202238,300 shares $333,210.00 -12.0%2.1%2.6 $8.70 11/30/202243,500 shares $424,560.00 +33.0%3.1%4.3 $9.76 11/15/202232,700 shares $310,813.50 -86.9%1.8%4.2 $9.51 10/31/2022250,400 shares $190,078.64 +76.2%N/A3.4 $0.76 10/15/2022142,100 shares $86,354.17 +91.3%N/A2 $0.61 9/30/202274,300 shares $54,239.00 +141.2%N/A1.2 $0.73 9/15/202230,800 shares $30,193.24 +106.7%N/A0.6 $0.98 8/31/202214,900 shares $16,464.50 -15.8%N/A0.5 $1.11 8/15/202217,700 shares $21,948.00 -44.5%N/A0.5 $1.24 7/31/202231,900 shares $38,120.50 -18.2%N/A0.9 $1.20 7/15/202239,000 shares $47,970.00 -13.5%N/A0.8 $1.23 6/30/202245,100 shares $52,541.50 +98.7%N/A0.7 $1.17 6/15/202222,700 shares $26,786.00 -56.4%N/A0 $1.18 5/31/202252,100 shares $69,814.00 -15.4%N/A0 $1.34 5/15/202261,600 shares $80,696.00 -16.4%N/A0.1 $1.31 4/30/202273,700 shares $95,073.00 -40.7%N/A0.1 $1.29 4/15/2022124,300 shares $197,637.00 -83.6%N/A0.1 $1.59 3/31/2022758,000 shares $1.26 million +282.4%N/A0.6 $1.66 3/15/2022198,200 shares $235,858.00 -32.3%1.4%0.1 $1.19 2/28/2022292,700 shares $371,729.00 +27.0%2.1%0.1 $1.27 2/15/2022230,500 shares $306,565.00 -42.7%1.7%0.1 $1.33 1/31/2022402,100 shares $526,751.00 +572.4%2.9%0.1 $1.31 1/15/202259,800 shares $99,268.00 -92.9%0.4%0 $1.66 12/31/2021836,200 shares $1.97 million +160.7%6.0%0.3 $2.35Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 12/15/2021320,800 shares $494,032.00 -4.0%2.3%0.1 $1.54 11/30/2021334,200 shares $574,824.00 -1.5%2.4%4.4 $1.72 11/15/2021339,200 shares $763,200.00 -16.6%2.4%3.9 $2.25 10/29/2021406,600 shares $845,728.00 -9.4%2.9%2.7 $2.08 10/15/2021449,000 shares $992,290.00 -32.0%3.2%0.5 $2.21 9/30/2021660,100 shares $1.45 million -4.9%4.7%0.8 $2.20 9/15/2021693,800 shares $1.59 million -12.7%5.0%0.8 $2.29 8/31/2021794,800 shares $2.14 million -2.7%5.7%1 $2.69 8/13/2021816,700 shares $1.88 million -43.3%5.9%1 $2.30 7/30/20211,440,000 shares $4.20 million +257.7%10.3%1.9 $2.92 7/15/2021402,600 shares $1.03 million +9.7%2.9%4.6 $2.57 6/30/2021367,000 shares $1.05 million -17.3%2.6%3.7 $2.87 6/15/2021443,900 shares $1.39 million +2.8%3.2%3.6 $3.14 5/28/2021431,900 shares $1.31 million -10.8%3.9%2.9 $3.03 5/14/2021484,000 shares $1.26 million -0.7%N/A2.3 $2.60 4/30/2021487,400 shares $1.56 million -12.1%N/A1.1 $3.21 4/15/2021554,500 shares $1.89 million -12.0%N/A0.8 $3.41 3/31/2021629,800 shares $2.37 million -18.4%N/A0.6 $3.77 3/15/2021772,000 shares $3.27 million -13.9%N/A0.7 $4.24 2/26/2021896,200 shares $3.72 million +8.3%N/A0.8 $4.15 2/12/2021827,800 shares $4.50 million -14.9%N/A0.7 $5.44 1/29/2021972,800 shares $5.35 million +36.8%N/A0.9 $5.50 1/15/2021710,900 shares $2.56 million +18.2%N/A0.4 $3.60 12/31/2020601,300 shares $1.79 million -11.7%N/A0.5 $2.98 12/15/2020681,200 shares $2.19 million +17.8%N/A0.6 $3.21 11/30/2020578,400 shares $1.87 million +77.8%N/A0.5 $3.23 11/15/2020325,300 shares $933,611.00 -44.5%N/A0.3 $2.87 10/30/2020586,500 shares $1.84 million +1,327.0%N/A0.7 $3.13 10/15/202041,100 shares $1.66 million +6.2%N/A0.1 $40.51 9/30/202038,700 shares $1.51 million +7.5%N/A0.4 $39.09 9/15/202036,000 shares $1.37 million +102.3%N/A0.3 $38.06 8/31/202017,800 shares $667,322.00 +20.3%N/A0.2 $37.49 8/14/202014,800 shares $485,884.00 -37.8%N/A0.1 $32.83 7/31/202023,800 shares $814,674.00 +23.3%N/A0.2 $34.23 7/15/202019,300 shares $931,225.00 +116.9%0.3%0.2 $48.25 6/30/20208,900 shares $205,590.00 +9.9%0.1%0.1 $23.10 6/15/20208,100 shares $157,302.00 +5.2%0.1%0.1 $19.42 5/29/20207,700 shares $153,230.00 -48.3%N/A0.1 $19.90 5/15/202014,900 shares $229,460.00 -55.3%N/A0.2 $15.40 BVXV Short Interest - Frequently Asked Questions What is BiondVax Pharmaceuticals' current short interest? Short interest is the volume of BiondVax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 4,900 shares of BVXV short. Learn More on BiondVax Pharmaceuticals' current short interest. Is BiondVax Pharmaceuticals' short interest increasing or decreasing? BiondVax Pharmaceuticals saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 4,900 shares, an increase of 36.1% from the previous total of 3,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.78 billion), Occidental Petroleum Co. ($3.04 billion), Royal Caribbean Cruises Ltd. ($2.10 billion), Celsius Holdings, Inc. ($1.98 billion), Coinbase Global, Inc. ($1.97 billion), T. Rowe Price Group, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.83 billion), Tractor Supply ($1.82 billion), Moderna, Inc. ($1.66 billion), and CarMax, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short BiondVax Pharmaceuticals stock? Short selling BVXV is an investing strategy that aims to generate trading profit from BiondVax Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BiondVax Pharmaceuticals? A short squeeze for BiondVax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BVXV, which in turn drives the price of the stock up even further. How often is BiondVax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BVXV, twice per month. The most recent reporting period available is August, 15 2023. More Short Interest Resources from MarketBeat Related Companies Apollomics Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze CERo Therapeutics Short Squeeze Clene Short Squeeze Conduit Pharmaceuticals Short Squeeze enGene Short Squeeze Fortress Biotech Short Squeeze Immatics Short Squeeze Jasper Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BVXV) was last updated on 5/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiondVax Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiondVax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
